HealthTree Logo
search more_vert

Clinical Expertise

  • Cancer
  • Chronic Lymphocytic Leukemia
  • Hairy Cell Leukemia
  • Hematologic Malignancies
  • HIV-related Lymphoma
  • Hodgkin's Disease
  • Leukemia
  • Lymphoma
  • Macroglobulinemia
  • Non-Hodgkin's Lymphoma
  • Ocular Lymphomas
  • Ophthalmic Tumors
  • Rare Cancer and Blood Disease Program

About

Dr. Hill is the Director of the Lymphoid Malignancies Program and a Staff Physician in the Cleveland Clinic Taussig Cancer Institute.  He received his undergraduate degree from Dartmouth College and earned his Ph.D. in genetics through work done at Cold Spring Harbor Laboratory.  He received his medical degree from the University of Chicago Pritzker School of Medicine where he also completed his residency in Internal Medicine.  He conducted his hematology/oncology fellowship at the Cleveland Clinic Taussig Cancer Institute.   His clinical and research focus is in chronic lymphocytic leukemia (CLL) and lymphoma.  He is the principal investigator of multiple on-going clinical trials of new cancer treatments including novel cellular therapies and has published extensive research articles pertaining to these topics.  He serves as the Chairman of the Pharmacy & Therapeutics (P&T) Committee within the Department of Hematology and Medical Oncology, Co-Director of the Lymphoid Malignancies Center of Excellence and serves on the editorial board of several peer reviewed journals. He is an Associate Professor of Medicine of the Cleveland Clinic Lerner College of Medicine is an active member of the Case Comprehensive Cancer Center, American Society of Hematology (ASH), and the Center for International Blood and Marrow Transplant Research (CIBMTR) and committee member of the National Comprehensive Cancer Network (NCCN).

Location

Cleveland Clinic: 9500 Euclid Ave # R35, Cleveland, OH 44195, USA

Get the latest thought leadership on CLL delivered straight to your inbox.

Subscribe to the weekly "HealthTree Community for CLL Newsletter" for CLL news, life with CLL stories, CLL clinical trials, CLL 101 articles and events with CLL experts.